Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$4.26 - $6.5 $3.04 Million - $4.64 Million
-714,220 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$5.03 - $8.8 $294,154 - $514,624
-58,480 Reduced 7.57%
714,220 $4.44 Million
Q4 2020

Feb 02, 2021

SELL
$4.04 - $5.31 $65,448 - $86,022
-16,200 Reduced 2.05%
772,700 $3.78 Million
Q3 2020

Nov 05, 2020

BUY
$3.64 - $7.76 $59,965 - $127,838
16,474 Added 2.13%
788,900 $3.32 Million
Q2 2020

Aug 12, 2020

BUY
$4.78 - $8.26 $356,492 - $616,030
74,580 Added 10.69%
772,426 $5.35 Million
Q1 2020

May 12, 2020

SELL
$4.0 - $21.53 $7,200 - $38,754
-1,800 Reduced 0.26%
697,846 $2.79 Million
Q4 2019

Jan 27, 2020

BUY
$13.94 - $24.12 $1.82 Million - $3.15 Million
130,740 Added 22.98%
699,646 $15 Million
Q3 2019

Oct 31, 2019

BUY
$13.89 - $23.16 $2.29 Million - $3.82 Million
165,125 Added 40.89%
568,906 $8.63 Million
Q2 2019

Aug 15, 2019

SELL
$16.27 - $20.51 $123,652 - $155,876
-7,600 Reduced 1.85%
403,781 $7.83 Million
Q1 2019

May 03, 2019

SELL
$12.61 - $22.33 $75,660 - $133,980
-6,000 Reduced 1.44%
411,381 $8.54 Million
Q4 2018

Feb 08, 2019

SELL
$12.41 - $22.98 $343,620 - $636,293
-27,689 Reduced 6.22%
417,381 $5.68 Million
Q3 2018

Nov 13, 2018

SELL
$2.45 - $16.27 $70,501 - $468,185
-28,776 Reduced 6.07%
445,070 $7.24 Million
Q2 2018

Aug 15, 2018

BUY
$2.68 - $3.48 $30,943 - $40,180
11,546 Added 2.5%
473,846 $1.46 Million
Q1 2018

May 11, 2018

SELL
$2.99 - $4.44 $59,202 - $87,912
-19,800 Reduced 4.11%
462,300 $1.39 Million
Q4 2017

Feb 06, 2018

BUY
$3.06 - $4.09 $35,496 - $47,444
11,600 Added 2.47%
482,100 $1.93 Million
Q3 2017

Nov 15, 2017

BUY
$3.03 - $3.72 $1.43 Million - $1.75 Million
470,500
470,500 $1.65 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $6.59B
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.